Skye Bioscience, Inc. (SKYE)
0.7449
-0.03
(-3.39%)
USD |
NASDAQ |
Feb 27, 16:00
0.75
+0.01
(+0.68%)
After-Hours: 20:00
Skye Bioscience Market Cap : 23.88M for Feb. 27, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 8.206B |
| Merck & Co., Inc. | 306.13B |
| ACADIA Pharmaceuticals, Inc. | 4.155B |
| Alnylam Pharmaceuticals, Inc. | 44.15B |
| Savara, Inc. | 1.225B |
Market Cap Related Metrics
| PEG Ratio | -0.0109 |
| Price to Book Value | 0.7272 |
| Price | 0.7449 |
| Earnings Yield | -173.2% |
| PEGY Ratio | -0.0109 |